268 related articles for article (PubMed ID: 18317916)
1. Secondary prevention after acute myocardial infarction and coronary revascularisation: focus on Angiotensin converting enzyme inhibitors.
Kaski JC; Fernandez-Berges D
Cardiovasc Drugs Ther; 2008 Jun; 22(3):185-91. PubMed ID: 18317916
[TBL] [Abstract][Full Text] [Related]
2. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M; Malmberg K; Ohrvik J; Rydén L;
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological prevention of coronary relapses in Italian clinical practice: a literature review].
Pedrinelli R; Ciccone M; Novo S; Catapano AL
G Ital Cardiol (Rome); 2012 Nov; 13(11):734-40. PubMed ID: 23096582
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention for patients following a myocardial infarction: summary of NICE guidance.
Skinner JS; Cooper A; Feder GS;
Heart; 2007 Jul; 93(7):862-4. PubMed ID: 17569811
[TBL] [Abstract][Full Text] [Related]
6. Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction.
Skinner JS; Minhas R
Heart; 2007 Jul; 93(7):864-6. PubMed ID: 17569812
[No Abstract] [Full Text] [Related]
7. Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non-Obstructive Coronary Arteries.
Choo EH; Chang K; Lee KY; Lee D; Kim JG; Ahn Y; Kim YJ; Chae SC; Cho MC; Kim CJ; Kim HS; Jeong MH;
J Am Heart Assoc; 2019 Jul; 8(14):e011990. PubMed ID: 31284804
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacotherapy following myocardial infarction].
Spinarová L; Spinar J; Vítovec J
Vnitr Lek; 2011 Nov; 57(11):966-9. PubMed ID: 22165705
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.
Meurice T; Tricot O; Lemesle G; Deneve M; Lejeune P; Biausque F; Cordier C; Savoye C; Hennebert O; Taghipour K; Sivery B; Pruvost P; Alaoui M; Carpentier L; Segrestin B; Lamblin N; Bauters C
Arch Cardiovasc Dis; 2015; 108(6-7):340-6. PubMed ID: 25858539
[TBL] [Abstract][Full Text] [Related]
10. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
Gitsels LA; Kulinskaya E; Steel N
BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
[TBL] [Abstract][Full Text] [Related]
11. Secondary prevention of coronary artery disease in contemporary clinical practice.
Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
[TBL] [Abstract][Full Text] [Related]
12. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.
Fisher M; Folland E
Am J Ther; 2008; 15(2):137-49. PubMed ID: 18356634
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
[TBL] [Abstract][Full Text] [Related]
14. [Evolution of secondary prevention medication prescriptions after myocardial revascularisation: the ANCOR survey].
Jullien G; Mosnier M; Danchin N
Ann Cardiol Angeiol (Paris); 2005 Aug; 54(4):184-9. PubMed ID: 16104618
[TBL] [Abstract][Full Text] [Related]
15. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
16. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
17. Myocardial infarction: management of the subacute period.
Mercado MG; Smith DK; McConnon ML
Am Fam Physician; 2013 Nov; 88(9):581-8. PubMed ID: 24364634
[TBL] [Abstract][Full Text] [Related]
18. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
[TBL] [Abstract][Full Text] [Related]
19. [Secondary prevention after myocardial infarction].
Czuriga I
Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
[TBL] [Abstract][Full Text] [Related]
20. Drug secondary prevention in postmenopausal women with ischemic heart disease.
Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
